{"id":"https://openalex.org/W2951473081","doi":"https://doi.org/10.1002/hon.127_2629","title":"HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR\u2010T CELL IMMUNOTHERAPY","display_name":"HIGH RATE OF DURABLE COMPLETE REMISSION IN FOLLICULAR LYMPHOMA AFTER CD19 CAR\u2010T CELL IMMUNOTHERAPY","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2951473081","doi":"https://doi.org/10.1002/hon.127_2629","mag":"2951473081"},"language":"en","primary_location":{"id":"doi:10.1002/hon.127_2629","doi":"https://doi.org/10.1002/hon.127_2629","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hon.127_2629","pdf_url":null,"source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043131622","display_name":"Alexandre V. Vinaud Hirayama","orcid":"https://orcid.org/0000-0001-7980-3882","observed_orcids":["https://orcid.org/0000-0001-7980-3882"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.V. Hirayama","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010158325","display_name":"Jordan Gauthier","orcid":"https://orcid.org/0000-0002-5769-8409","observed_orcids":["https://orcid.org/0000-0002-5769-8409"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Gauthier","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078301390","display_name":"Kevin Anthony Hay","orcid":"https://orcid.org/0000-0002-9398-2677","observed_orcids":["https://orcid.org/0000-0002-9398-2677"]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"K.A. Hay","raw_affiliation_strings":["Department of Medicine University of British Columbia  Vancouver Canada","Department of Medicine, University of British Columbia, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine University of British Columbia  Vancouver Canada","institution_ids":["https://openalex.org/I141945490"]},{"raw_affiliation_string":"Department of Medicine, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057524392","display_name":"Jenna M. Voutsinas","orcid":"https://orcid.org/0000-0002-7474-4892","observed_orcids":["https://orcid.org/0000-0002-7474-4892"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.M. Voutsinas","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027819567","display_name":"Qian Vicky Wu","orcid":"https://orcid.org/0000-0002-2292-4816","observed_orcids":["https://orcid.org/0000-0002-2292-4816"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Q. Wu","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049889417","display_name":"Alyssa Sheih","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Sheih","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082136384","display_name":"Janaki Purushe","orcid":"https://orcid.org/0000-0001-7767-2700","observed_orcids":["https://orcid.org/0000-0001-7767-2700"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Purushe","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109310755","display_name":"Barbara S. Pender","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B.S. Pender","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009027945","display_name":"Reed M. Hawkins","orcid":"https://orcid.org/0000-0001-8611-2588","observed_orcids":["https://orcid.org/0000-0001-8611-2588"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.M. Hawkins","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029498424","display_name":"Aesha Vakil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Vakil","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Phi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Phi","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061167339","display_name":"Rachel N. Steinmetz","orcid":"https://orcid.org/0000-0001-8847-112X","observed_orcids":["https://orcid.org/0000-0001-8847-112X"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.N. Steinmetz","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087281332","display_name":"Stanley R. Riddell","orcid":"https://orcid.org/0000-0002-4688-9920","observed_orcids":["https://orcid.org/0000-0002-4688-9920"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.R. Riddell","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016684714","display_name":"David G. Maloney","orcid":"https://orcid.org/0000-0002-8477-6919","observed_orcids":["https://orcid.org/0000-0002-8477-6919"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.G. Maloney","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089990813","display_name":"Cameron John Turtle","orcid":"https://orcid.org/0000-0002-4722-4461","observed_orcids":["https://orcid.org/0000-0002-4722-4461"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.J. Turtle","raw_affiliation_strings":["Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division Fred Hutchinson Cancer Research Center  Seattle United States","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, United States","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":2.1765,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.89344919,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"37","issue":"S2","first_page":"170","last_page":"171"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.8980000019073486},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8579999804496765},{"id":"https://openalex.org/keywords/sustained-remission","display_name":"sustained remission","score":0.7620000243186951},{"id":"https://openalex.org/keywords/histological-transformation","display_name":"histologic transformation","score":0.9070000052452087},{"id":"https://openalex.org/keywords/relapsed-refractory-b-cell-lymphoma","display_name":"relapsed/refractory B-cell lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.6549999713897705},{"id":"https://openalex.org/keywords/high-risk-disease","display_name":"high-risk disease","score":0.5339999794960022},{"id":"https://openalex.org/keywords/flipi-score","display_name":"FLIPI score","score":0.7009999752044678},{"id":"https://openalex.org/keywords/treatment-response-durability","display_name":"treatment response durability","score":0.33899998664855957},{"id":"https://openalex.org/keywords/time-to-remission","display_name":"time to remission","score":0.42800000309944153}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8284278512001038},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.7279937267303467},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.6929628849029541},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6698890924453735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5333908200263977},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4721422493457794},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.46066632866859436},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4370793104171753},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4199545681476593},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3974936604499817},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.351461261510849},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34546294808387756},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32163703441619873},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2162412703037262},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18707579374313354}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/hon.127_2629","doi":"https://doi.org/10.1002/hon.127_2629","is_oa":false,"landing_page_url":"https://doi.org/10.1002/hon.127_2629","pdf_url":null,"source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2586991593","https://openalex.org/W2349603434","https://openalex.org/W2105571216","https://openalex.org/W2112473520","https://openalex.org/W2557262035","https://openalex.org/W2062566755","https://openalex.org/W2400758223","https://openalex.org/W2093161300","https://openalex.org/W4389668809","https://openalex.org/W2084396664"],"abstract_inverted_index":{"Introduction:":[0],"Patients":[1],"(pts)":[2],"with":[3,6,46,61,68,92,169,222,285,299,332,343],"follicular":[4,47,62,424],"lymphoma":[5,30,48,63,425],"early":[7],"relapse":[8],"after":[9,34,180,232],"initial":[10],"chemoimmunotherapy":[11,168],"have":[12,49,72],"limited":[13],"survival,":[14],"as":[15],"do":[16],"those":[17],"who":[18,125,247,308],"fail":[19],"multiple":[20],"regimens":[21],"or":[22,67,191,203,214,400,410,418],"develop":[23],"histologic":[24,69],"transformation":[25,65,70],"to":[26,103,115,238],"large":[27],"cell":[28,42,88,195,396],"non-Hodgkin":[29],"(NHL).":[31],"Initial":[32],"responses":[33,58,99],"CD19-directed":[35],"chimeric":[36],"antigen":[37],"receptor":[38],"(CAR)-modified":[39],"T":[40],"(CAR-T)":[41],"immunotherapy":[43,89],"in":[44,59,90,139,251,267,278,393,398],"pts":[45,60,124,143,154,221,284,302,307,331,356,392],"been":[50,74],"reported;":[51],"however,":[52,353],"the":[53,104,181,282,287,311,401],"incidence":[54,402],"and":[55,109,118,128,147,173,184,210,245,345,350,371,390,403,461,482,487,519,527,538],"durability":[56],"of":[57,85,159,219,405],"without":[64,253,291],"(FL)":[66],"(tFL)":[71],"not":[73],"established.":[75],"Methods:":[76],"We":[77],"conducted":[78],"a":[79,157,457,470,490,509,514,534],"phase":[80],"1/2":[81],"clinical":[82],"trial":[83],"(NCT01865617)":[84],"CD19":[86,134],"CAR-T":[87,135,233,395],"adults":[91],"relapsed/refractory":[93],"(R/R)":[94],"CD19+":[95],"B-cell":[96],"malignancies.":[97],"Best":[98],"were":[100,113,386,420],"reported":[101],"according":[102],"Lugano":[105],"criteria.":[106],"Fisher's":[107],"exact":[108],"Wilcoxon":[110],"rank-sum":[111],"tests":[112],"used":[114],"compare":[116],"categorical":[117],"non-categorical":[119],"variables,":[120],"respectively.":[121],"Results:":[122],"Twenty-one":[123],"received":[126,156],"cyclophosphamide":[127],"fludarabine":[129],"lymphodepletion":[130],"followed":[131],"by":[132],"2x106":[133],"cells/kg":[136],"are":[137],"included":[138],"this":[140,272],"study.":[141],"Eight":[142],"(38%)":[144],"had":[145,150,155,166,177,186,200,207,212,347,357,373],"FL":[146,153,223,269,344,362,389],"13":[148,283],"(62%)":[149],"tFL.":[151],"The":[152,235,326],"median":[158,236,312,322,327],"4":[160],"prior":[161,188],"therapies":[162],"(range,":[163,243],"2-7);":[164],"all":[165,246,300,330],"failed":[167,187],"an":[170],"anti-CD20":[171],"antibody":[172],"alkylating":[174],"agents;":[175],"75%":[176,199,211],"progressive":[178],"disease":[179],"last":[182],"therapy;":[183],"50%":[185],"autologous":[189],"(n=3)":[190],"allogeneic":[192],"(n=1)":[193],"hematopoietic":[194],"transplantation.":[196],"Before":[197],"lymphodepletion,":[198],"stage":[201],"III":[202],"IV":[204],"disease;":[205],"62%":[206],"extranodal":[208],"involvement;":[209],"intermediate":[213],"high":[215],"FLIPI":[216],"score.":[217],"Seven":[218],"8":[220],"achieved":[224,248,309],"complete":[225],"remission":[226,252],"(CR,":[227],"88%;":[228],"95%":[229],"CI,":[230,297,320,338],"47-99)":[231],"cells.":[234],"time":[237],"CR":[239,249,264],"was":[240,265,294,316,334],"29":[241],"days":[242],"27-42),":[244],"remained":[250],"additional":[254,292],"therapy":[255,273,293],"(median":[256],"follow-up,":[257],"24":[258],"months).":[259,325],"Despite":[260],"high-risk":[261],"disease,":[262],"durable":[263],"observed":[266,387],"most":[268],"pts,":[270],"indicating":[271],"should":[274],"be":[275],"further":[276],"investigated":[277],"larger":[279],"studies.":[280],"For":[281,305],"tFL,":[286,364],"best":[288],"overall":[289],"response":[290],"46%":[295],"(95%":[296,319,337],"20-74),":[298],"responding":[301],"achieving":[303],"CR.":[304],"tFL":[306,333,346,355,391],"CR,":[310],"progression-free":[313],"survival":[314],"(PFS)":[315],"11.2":[317],"months":[318,336],"3.3-NR;":[321],"follow-up":[323],"38":[324],"PFS":[328],"for":[329],"1.4":[335],"1.2-NR)":[339],"[Figure":[340],"1].":[341],"Pts":[342],"comparable":[348],"baseline":[349],"treatment":[351],"characteristics;":[352],"more":[354],"elevated":[358],"lactate":[359],"dehydrogenase":[360],"(LDH;":[361],"vs":[363,366,378],"13%":[365],"69%,":[367],"P":[368,380],"=":[369,381],".02)":[370],"fewer":[372],"bone":[374],"marrow":[375],"involvement":[376],"(50%":[377],"15%,":[379],".15).":[382],"No":[383,413],"significant":[384],"differences":[385],"between":[388],"peak":[394],"counts":[397],"blood,":[399],"severity":[404],"cytokine":[406],"release":[407],"syndrome":[408],"(CRS)":[409],"neurotoxicity":[411],"(NT).":[412],"severe":[414],"(grade":[415],"\u22653)":[416],"CRS":[417],"NT":[419],"observed.":[421],"Keywords:":[422],"CD19;":[423],"(FL);":[426],"T-cells.":[427],"Disclosures:":[428],"Hirayama,":[429],"A:":[430,441],"Honoraria:":[431,476],"DAVA":[432],"Oncology.":[433],"Hay,":[434],"K:":[435],"Consultant":[436,448,496],"Advisory":[437,449,497],"Role:":[438,450,498],"Celgene.":[439],"Vakil,":[440],"Stock":[442,463,521],"Ownership:":[443,464,522],"Nektar":[444,517,539],"Therapeutics.":[445,540],"Riddell,":[446],"S:":[447],"Adaptive":[451],"Biotechnologies,":[452],"Cell":[453],"Medica,":[454],"Juno":[455,468,488,507,532],"Therapeutics,":[456,469,489,502,508,518,526,533],"Celgene/Bristol-Myers":[458,471,491,510,535],"Squibb":[459,472,492,511,536],"company,":[460,512,537],"NOHLA;":[462],"Celgene;":[465],"Research":[466,484,530],"Funding:":[467,485,531],"company.":[473,493],"Maloney,":[474],"D:":[475],"Janssen":[477],"Scientific":[478],"Affairs,":[479],"Seattle":[480],"Genetics,":[481],"Roche/Genentech;":[483],"GlaxoSmithKline,":[486],"Turtle,":[494],"C:":[495],"Caribou":[499,523],"Biosciences,":[500,504,524],"Eureka":[501,525],"Precision":[503,528],"Aptevo,":[505],"Humanigen,":[506],"Kite,":[513],"Gilead":[515],"Company,":[516],"Novartis;":[520],"Biosciences;":[529]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}